Cross-Cohort Computational Inference of miRNA-mRNA Regulatory Programs from scRNA-seq in Convalescent Monocytes Associated with Prior COVID-19 Severity
Findings provide a computational framework for investigating inferred miRNA associations of monocyte inflammatory pathways associated with prior COVID-19 severity and highlight regulatory interactions that warrant further experimental validation.
Abstract
Severe coronavirus disease 2019 (COVID-19) is characterized by acute immune dysregulation, with monocytes playing a central role in driving inflammation and disease severity. However, the transcriptional and post-transcriptional regulatory mechanisms underlying monocyte dysfunction in severe COVID-19 remain unexplored. In the study, an integrative analysis of paired bulk RNA-seq and miRNA-seq datasets was performed together with independent single-cell RNA-seq (scRNA-seq) data from convalescent individuals with a history of ICU or non-ICU COVID-19. Pooled cell proportions descriptively indicated a higher proportion of classical monocytes and lower proportions of non-classical monocytes, B cells and dendritic cells in individuals with a history of ICU disease; however, none of these differences was statistically significant in patient-level analyses after multiple-testing correction. Using the miRSCAPE framework, miRNA expression was inferred at single-cell resolution and identified distinct cluster-specific inferred miRNA expression patterns. Differential expression analysis of classical monocyte populations identified 284 nominally significant differentially expressed genes between convalescent ICU and non-ICU samples. Integration of miRNA-mRNA correlation analysis with experimentally validated interactions and independent assessment highlighted a focused regulatory network centered on ZMAT3, RHOB and HLA-DQA1. Host–pathogen interaction analysis identified database-supported SARS-CoV-2-host interactions involving ORF3a-RHOB and nucleoprotein-RHPN2, with additional host–host interactions connecting RHPN2, HLA-C and HLA-DQA1. Collectively, these findings provide a computational framework for investigating inferred miRNA associations of monocyte inflammatory pathways associated with prior COVID-19 severity and highlight regulatory interactions that warrant further experimental validation.
This study provides the first genome-wide H3K4me3 characterization of circulating immune cells during acute critical COVID-19, demonstrating that epigenetic reprogramming is an active and dynamic process that mirrors the functional immune dysregulation observed in these patients.
Jan Niklas Thon, J. Schenz, Mascha O. Fiedler et al.· Frontiers in Immunology· 1 citation
IL1R2 identifies a highly inflammatory monocyte state associated with COVID-19 immune dysregulation, supporting its potential role as a complementary prognostic biomarker and therapeutic target.
Yi-Ying Yang, Fang Yu, Mu-Yuan Li et al.· Shock· 0 citations
TP53INP1 is identified as a hypothesis-generating candidate linking HAdV-7-associated whole-blood methylation changes with B-cell regulatory networks observed in an external sepsis dataset, given the small discovery cohort and absence of experimental validation.
Pei-Dan Hu, Bo Huang, Wen-Min Yang et al.· Pathogens· 0 citations
Integrative transcriptomic profiling identified peripheral T-cell dysregulation in CAP and highlighted CD8B, GZMM, MYL12B, and TUBA1A as candidate blood biomarkers.
Hua-Chi Jiang, Xiao-Qi Fan, Shu-Fang Zhou et al.· International Journal of Med...· 0 citations
An association between the expression of lactoferrin (LTF) and its receptor, LDL receptor-related protein 11 (LRP11), and susceptibility to severe COVID-19 was identified, highlighting a potentially relevant signaling axis in disease pathogenesis.
Ana Luiza Labbate Bonaldo, Jeferson dos Santos Souza, Jakeline Santos Oliveira et al.· Genes· 0 citations
Findings identify transcriptomic signatures associated with potential COVID-19 susceptibility across innate, adaptive, and vascular immune-related axes and provide an exploratory framework for risk classification and potential precision prevention.
Yu-Ting Xin, Chao Yi, Wei Zhu et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.